Cargando…

A Combination of Caffeine Supplementation and Enriched Environment in an Alzheimer’s Disease Mouse Model

A variety of factors has been associated with healthy brain aging, and epidemiological studies suggest that physical activity and nutritional supplements such as caffeine may reduce the risk of developing dementia and, in particular, Alzheimer’s disease (AD) in later life. Caffeine is known to act a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stazi, Martina, Zampar, Silvia, Klafki, Hans-Wolfgang, Meyer, Thomas, Wirths, Oliver
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9916825/ https://www.ncbi.nlm.nih.gov/pubmed/36768476 http://dx.doi.org/10.3390/ijms24032155

Ejemplares similares

Combined long-term enriched environment and caffeine supplementation improve memory function in C57Bl6 mice
por: Stazi, Martina, et al.
Publicado: (2022)

Physical Activity Ameliorates Impaired Hippocampal Neurogenesis in the Tg4-42 Mouse Model of Alzheimer’s Disease
por: Gerberding, Anna-Lina, et al.
Publicado: (2019)

Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
por: Wirths, Oliver, et al.
Publicado: (2020)

Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau
por: Zampar, Silvia, et al.
Publicado: (2021)

N-truncated Aβ(4–x) peptides in sporadic Alzheimer’s disease cases and transgenic Alzheimer mouse models
por: Wirths, Oliver, et al.
Publicado: (2017)

Long-term caffeine treatment of Alzheimer mouse models ameliorates behavioural deficits and neuron loss and promotes cellular and molecular markers of neurogenesis
por: Stazi, Martina, et al.
Publicado: (2021)

Chronic Memantine Treatment Ameliorates Behavioral Deficits, Neuron Loss, and Impaired Neurogenesis in a Model of Alzheimer’s Disease
por: Stazi, Martina, et al.
Publicado: (2020)

N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer’s disease
por: Zampar, S., et al.
Publicado: (2020)

A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease
por: Shahpasand-Kroner, Hedieh, et al.
Publicado: (2018)

Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer’s disease
por: Aichholzer, Freyja, et al.
Publicado: (2021)

Is plasma amyloid-β 1–42/1–40 a better biomarker for Alzheimer’s disease than AβX–42/X–40?
por: Klafki, Hans-Wolfgang, et al.
Publicado: (2022)

Glycoprotein NMB: a novel Alzheimer’s disease associated marker expressed in a subset of activated microglia
por: Hüttenrauch, Melanie, et al.
Publicado: (2018)

Neuron Loss in Transgenic Mouse Models of Alzheimer's Disease
por: Wirths, Oliver, et al.
Publicado: (2010)

Development and Technical Validation of an Immunoassay for the Detection of APP(669–711) (Aβ(−3–40)) in Biological Samples
por: Klafki, Hans W., et al.
Publicado: (2020)

Matrix Development for the Detection of Phosphorylated Amyloid-β Peptides by MALDI-TOF-MS
por: Liepold, Thomas, et al.
Publicado: (2023)

Deposition of C-terminally truncated Aβ species Aβ37 and Aβ39 in Alzheimer’s disease and transgenic mouse models
por: Reinert, Jochim, et al.
Publicado: (2016)

Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model
por: Hüttenrauch, M, et al.
Publicado: (2016)

Meprin β knockout reduces brain Aβ levels and rescues learning and memory impairments in the APP/lon mouse model for Alzheimer’s disease
por: Marengo, Liana, et al.
Publicado: (2022)

Loss of Hippocampal Calretinin and Parvalbumin Interneurons in the 5XFAD Mouse Model of Alzheimer’s Disease
por: Giesers, Naomi K., et al.
Publicado: (2020)

Brain Region-Specific Differences in Amyloid-β Plaque Composition in 5XFAD Mice
por: Bader, Angelika Sabine, et al.
Publicado: (2023)

Entorhinal Cortex dysfunction can be rescued by inhibition of microglial RAGE in an Alzheimer’s disease mouse model
por: Criscuolo, Chiara, et al.
Publicado: (2017)

Intracellular Accumulation of Amyloid-Beta – A Predictor for Synaptic Dysfunction and Neuron Loss in Alzheimer's Disease
por: Bayer, Thomas A., et al.
Publicado: (2010)

Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer’s disease
por: Bayer, Thomas A., et al.
Publicado: (2014)

Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation
por: Christensen, Ditte Z., et al.
Publicado: (2014)

The effects of supplementation with P-Synephrine alone and in combination with caffeine on resistance exercise performance
por: Ratamess, Nicholas A., et al.
Publicado: (2015)

Neuroprotective Effect of Caffeine in Alzheimer’s Disease
por: M Yelanchezian, Y Mukish, et al.
Publicado: (2022)

Acute caffeine supplementation in combat sports: a systematic review
por: López-González, Luis M., et al.
Publicado: (2018)

Caffeine Supplementation Strategies Among Endurance Athletes
por: Kreutzer, Andreas, et al.
Publicado: (2022)

Caffeine for Prevention of Alzheimer’s Disease: Is the A(2A) Adenosine Receptor Its Target?
por: Merighi, Stefania, et al.
Publicado: (2023)

Effects of Long-Term Environmental Enrichment on Anxiety, Memory, Hippocampal Plasticity and Overall Brain Gene Expression in C57BL6 Mice
por: Hüttenrauch, Melanie, et al.
Publicado: (2016)

Caffeine metabolites are associated with different forms of caffeine supplementation and with perceived exertion during endurance exercise
por: Whalley, Peter, et al.
Publicado: (2020)

Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)

Reproducibility of Alzheimer’s Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions
por: Vogelgsang, Jonathan, et al.
Publicado: (2018)

The Effects of Caffeine Supplements on Exercise-Induced Oxidative Damages
por: Zeraatpishe, Akbar, et al.
Publicado: (2015)

Caffeine supplementation affects the immunometabolic response to concurrent training
por: Rossi, Fabrício Eduardo, et al.
Publicado: (2017)

Caffeine Supplementation for Powerlifting Competitions: An Evidence-Based Approach
por: Grgic, Jozo, et al.
Publicado: (2019)

The influence of caffeinated and non-caffeinated multi-ingredient pre-workout supplements on resistance exercise performance and subjective outcomes
por: Stratton, Matthew T., et al.
Publicado: (2022)

Intraneuronal pyroglutamate-Abeta 3–42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model
por: Wirths, Oliver, et al.
Publicado: (2009)

An enriched environment delays the progression from mild cognitive impairment to Alzheimer's disease in senescence-accelerated mouse prone 8 mice
por: Li, Jian-Zhong, et al.
Publicado: (2021)

Effects of acute sleep deprivation and caffeine supplementation on anaerobic performance
por: Moore, Joss, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ce196vv0ua21386b9d7c1mjnkc